Life sciences marketing is entering a new phase of maturity—one defined not by the quest for generic brand “awareness,” but by the activation of programs that drive targeted, relevant and outcome-oriented engagement with healthcare professionals and patient audiences alike.

With results grounded in an intensive primary research effort (including surveys and interviews of over 120 senior life sciences marketers and other industry thought leaders), A Prescription for Precision: The Data-Driven Future of Life Sciences Marketing explores how brands are operationalizing the practice of precision marketing to drive measurable business and health outcomes.

What You’ll Learn:

• Precision marketing is now a budget priority: Over 90% of U.S. life sciences marketers are increasing investment in data-driven, omnichannel marketing programs—driven by demand for greater accountability and performance 
• Use cases are expanding rapidly: From engaging hard-to-reach HCP audiences to improving patient education and adherence 
• AI is accelerating precision strategies: Marketers are leveraging AI to improve both campaign effectiveness and operational efficiency
• Regulatory uncertainty is reinforcing the shift: Precision marketing is emerging as a potential “safe harbor” approach amid the threat of looming restrictions on the use of traditional advertising channels   

Why It Matters:

• As audience expectations rise and traditional channels fragment, life sciences brands are under pressure to deliver more relevant, measurable and compliant engagement. Precision marketing is no longer a niche capability—it’s becoming the foundation of modern commercial strategy.